Business
Cannabics Pharmaceuticals Inc. Appoints New Members to its Board of Advisors
Cannabics Pharmaceuticals Inc. Appoints New Members to its Board of Advisors.
About this update from Cnbx Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\n\nCannabics Pharmaceuticals Inc. Appoints New Members to its Board of Advisors\n\n\n\n\n\nCannabics Pharmaceuticals Inc. Appoints New Members to its Board of Advisors\nPR Newswire\nTEL AVIV, Israel, March 9, 2017\n\n\n\nTEL AVIV, Israel, March 9, 2017 /PRNewswire/ --\n\nCannabics' Pharmaceutical (CNBX) Board of Directors is proud to announce its addition of several highly-respected professionals to its Board of Advisors. The new Advisors are Dr. Gil Feiler, Dr. Martin Burow, Dr.Tal Mofkadi, Prof. Amos Toren and Dr. Sigalit Ariely-Portnoy.\n\n     (Logo: http://photos.prnewswire.com/prnh/20170223/471376LOGO )\n\n\n\"We are honored to have the newly appointed members on our team, sharing the research on the therapeutic values of cannabinoids,\" said Dr. Eyal Ballan, CTO of Cannabics Pharmaceuticals.\n\nThe company's Board of Advisors are:\n\nDr. Gil Feiler - Head of Advisory Board and Business Development Advisor. Dr. Feiler is a banker and hedge fund manager. Dr. Feiler served as Board Member of Advanced Vision Technology, traded on the Frankfurt Stock Exchange (VSJ), served on the Board of Safra Bank Mutual Fund Division; and has served as Administrative advisor for the Government of Ras Al Khaimah, UAE. Dr. Feiler has published extensively on business opportunities and strategies and was a frequent speaker in world events including the World Economic Forum in Davos.\n\nProf. Amos Toren, MD, Medical Advisor. Prof. Amos Toren is the Director of Pediatric Hemato-Oncology and BMT Department at the Sheba Medical Center since 2001 and a Professor in the division of Hematology, Sackler School of Medicine Tel-Aviv University. Prof. Toren is a specialist in Pediatrics, General Hematology and Pediatric Hemato-Oncology. He also has a PhD degree in genetics and qualified as a Master of Health Administration (MHA) at the Recannati Business School, Tel-Aviv University. Professor Toren runs numerous clinical studies, investigator initiated, company initiated, unicenter as well as multicenter.\n\nDr. Martin Burow, Scientific Advisor. Dr. Martin Burow is the founder and owner of DMB-Diagnostics GmbH and a specialist at medical sales and marketing activities in Asia and Europe. Dr. Burow specializes in the development and sale of devices for diagnostic analysis and diagnostic markers. Dr. Burow holds a Phd in BioChemist...